ITRXinTerra Resources Corp.
Price Chart
Loading chart...
About inTerra Resources Corp. (ITRX)
inTerra Resources Corp. (ITRX) is a Biotechnology company headquartered in Torrance, CA, United States whose shares trade over-the-counter on the Pink tier.
inTerra Resources Corp. is a holding company with interest in biopharmaceuticals, health and wellness, beauty and cosmetics industries. The Company's main operating subsidiary in Helica, LLC. a California limited liabilities company that holds exclusive distribution licenses from Sol Biotech, LLC., which is focused on RNA viruses, including fusion inhibitors and immune-boosting nutritional supplements.
Products and services
The Company's main operating subsidiary in Helica, LLC. a California limited liabilities company that holds exclusive distribution licenses from Sol Biotech, LLC., which is focused on RNA viruses, including fusion inhibitors and immune-boosting nutritional supplements.
ITRX key facts
- Ticker symbol
- ITRX
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Torrance, CA, United States
- Country of incorporation
- US
- Year of incorporation
- 1998
- Employees
- 3
- Estimated market cap
- $12.98M (as of Apr 16, 2025)
- Shares outstanding
- 309,104,700
- Reporting standard
- Alternative Reporting Standard
- Audit status
- Unaudited
- Fiscal year end
- 12/31
- Latest filing
- Annual Report (Dec 31, 2024)
inTerra Resources Corp. leadership
- Robert E. Altermatt — President, CEO
- Frank lkechukwu Igwealor — CFO
- Chanda Zaveri — Chief Scientific Officer
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with I
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for inTerra Resources Corp. (ITRX) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Company Officers
Social Media
Business Details
Stock Details
Loading modules...